An update in the New England Journal of Medicine has shown that transcatheter arterialization of the deep veins (TADV) using the LimFlow System is a reliable and long-lasting therapy helping patients ...
DETROIT (March 21, 2024) – The first commercial procedure on a patient in Michigan using the LimFlow System was performed earlier this month by vascular and endovascular surgeon Tamer Boules, M.D., ...
Breakthrough procedure reduces amputation risk for patients with Chronic Limb-Threatening Ischemia We're not only saving legs–we're enabling these patients to retain their independence, lessen the ...
ASHLAND — In 2024, UK King’s Daughters became the first hospital in Kentucky — and the only hospital in the region — to offer a new minimally invasive procedure for the treatment of chronic limb ...
The PROMISE II U.S. pivotal clinical trial found that minimally invasive LimFlow therapy enabled most patients to avoid amputation and experience wound healing. The procedure is designed to bypass ...
PARIS & SAN JOSE, Calif.--(BUSINESS WIRE)--LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of ...
A study published in the New England Journal of Medicine has shown that there may finally be an alternative to amputation for patients suffering from chronic limb-threatening ischemia (CLTI), the most ...
MIAMI, Nov. 7, 2024 /PRNewswire/ -- Pedro Martinez-Clark, MD, FACC, a renowned Harvard-trained cardiologist and founder of Amavita Heart and Vascular™, has joined forces with LimFlow® to offer an ...
Patients with a severe form of peripheral artery disease had low amputation rates, improved wound healing, and better quality of life 6 months after a procedure to reroute blood flow using LimFlow ...
SINGAPORE - Media OutReach - 18 September 2023-M&L Healthcare, in its first major MedTech investment, has announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA ...
CHEYENNE – Chronic Limb Threatening Ischemia (CLTI), a severe form of peripheral arterial disease (PAD), often leads to limb loss and diminished quality of life for patients with advanced disease.